# Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014)

> **NCT02141581** · PHASE4 · COMPLETED · sponsor: **Stanford University** · enrollment: 86 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Fluzone® (IM)
- **BIOLOGICAL:** Fluzone® Intradermal (ID)
- **BIOLOGICAL:** 2011-2012 FluMist®

## Key facts

- **NCT ID:** NCT02141581
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2018-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02141581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02141581, "Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02141581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*